Quest Diagnostics (NASDAQ:DGX) posted better-than-expected earnings for the third quarter on Tuesday.While Quest Diagnostics raised its revenue and adjusted earnings guidance for full-year 2025, the company lowered its GAAP earnings per share guidance to a range of $8.58 to$8.66 from a prior range of $8.60 to$8.80, which may be weighing on shares.The company brought in $2.82 billion in revenue, which was up 13.1$2.74 billion. Quest also reported adjusted earnings ...